August 1, 2013
Gold In September (G9)
709 Milwaukee Street, Suite A
Delafield, WI 53018
Dear Project Director:
It is my great pleasure to write a letter in support of the Gold In September (G9) Childhood Cancer Project. The G9 Project focuses on the great need to increase public awareness of childhood cancer, the leading cause of disease related death in children in the US, throughout the nation. Awareness of childhood cancer, and awareness for the need for more research, has fallen far short of the goal. With gold as the national color for childhood cancer and September as the recognized National Childhood Cancer Awareness Month, the G9 Project combines impact with simplicity.
As a pediatrician and pediatric oncologist, I perhaps should not have been surprised that it was Annie Bartosz, an 11-year-old, who created the concept for the G9 Project. Annie not only believes that childhood cancer deserves the same public awareness as adult cancers, she decided to take action. Even though her twin brother lost his battle with pediatric cancer in 2012, Annie is continuing his fight, striving to make a difference for every child with cancer, and inspiring others to do the same.
The G9 Project’s goal of helping to galvanize the childhood cancer community in support of every child, everywhere fighting cancer will be a key to its success. The G9 Project’s altruistic approach supports childhood cancer research by including all children fighting cancer, in all regions across the country, underneath a golden umbrella of optimism for the future. In order to serve every child everywhere, this truly impressive endeavor will support the Children’s Oncology Group’s (COG) Project: EveryChild and will also distribute funds to the G9 Centers of Excellence, which includes all 21 Children’s Oncology Group Phase 1 and Pilot Consortium locations.
The G9 Project has tremendous potential for the childhood cancer community, and I am proud to support their mission. I am confident that the G9 Project will accelerate awareness of childhood cancer and lead us closer to finding better cures and saving children’s lives.
With sincere hope for progress,
Peter C. Adamson, M.D.
Chair, Children’s Oncology Group
Professor of Pediatrics & Pharmacology
University of Pennsylvania School of Medicine at
The Children's Hospital of Philadelphia